Adults

Healthcare Solutions for Busy Adults

Healthcare Solutions for Busy Adults

Healthcare Solutions for Busy Adults

Juggling work, family, and personal health can be a challenge. We provide convenient, high-quality care for adults, including preventative screenings, urgent care, and management of common conditions.ule appointments for the same or next day and enjoy 24/7 virtual care through Calendly.

Juggling work, family, and personal health can be a challenge. We provide convenient, high-quality care for adults, including preventative screenings, urgent care, and management of common conditions.ule appointments for the same or next day and enjoy 24/7 virtual care through Calendly.

Juggling work, family, and personal health can be a challenge. We provide convenient, high-quality care for adults, including preventative screenings, urgent care, and management of common conditions.ule appointments for the same or next day and enjoy 24/7 virtual care through Calendly.

They Care About Your Health

Each team member contributes a unique set of skills and passion, united by a shared commitment to delivering exceptional healthcare experiences.

Drug-Resistant Acne

Next-gen acne treatment for the antibiotic era

VB1953 treats resistant P. acnes strains while calming inflammation. Offering hope for millions failed by existing topicals. - Dual action: DNA gyrase + TLR-MD2 inhibition - Proven efficacy in clindamycin non-responders - Best-in-class safety profile

Malignant Fungating Wounds

Bringing dignity back to late-stage cancer care

Vyome’s VB1953A is the first targeted therapy for MFW. Reducing odor, pain, and inflammation through a dual mechanism. - 75% odor reduction in early trials - No approved drugs exist today - Orphan designation potential

Uveitis

A safer path for vision preservation

VT1908, our non-steroidal eye drop, matches steroid performance in preclinical models—without the risks. - Targets IMPDH to block immune cell overactivity - Designed for patients who can’t use steroids - Efficient regulatory path for rare indication

Drug-Resistant Acne

Next-gen acne treatment for the antibiotic era

VB1953 treats resistant P. acnes strains while calming inflammation. Offering hope for millions failed by existing topicals. - Dual action: DNA gyrase + TLR-MD2 inhibition - Proven efficacy in clindamycin non-responders - Best-in-class safety profile

Malignant Fungating Wounds

Bringing dignity back to late-stage cancer care

Vyome’s VB1953A is the first targeted therapy for MFW. Reducing odor, pain, and inflammation through a dual mechanism. - 75% odor reduction in early trials - No approved drugs exist today - Orphan designation potential

Uveitis

A safer path for vision preservation

VT1908, our non-steroidal eye drop, matches steroid performance in preclinical models—without the risks. - Targets IMPDH to block immune cell overactivity - Designed for patients who can’t use steroids - Efficient regulatory path for rare indication

Drug-Resistant Acne

Next-gen acne treatment for the antibiotic era

VB1953 treats resistant P. acnes strains while calming inflammation. Offering hope for millions failed by existing topicals. - Dual action: DNA gyrase + TLR-MD2 inhibition - Proven efficacy in clindamycin non-responders - Best-in-class safety profile

Malignant Fungating Wounds

Bringing dignity back to late-stage cancer care

Vyome’s VB1953A is the first targeted therapy for MFW. Reducing odor, pain, and inflammation through a dual mechanism. - 75% odor reduction in early trials - No approved drugs exist today - Orphan designation potential

Uveitis

A safer path for vision preservation

VT1908, our non-steroidal eye drop, matches steroid performance in preclinical models—without the risks. - Targets IMPDH to block immune cell overactivity - Designed for patients who can’t use steroids - Efficient regulatory path for rare indication

See Why Families Love Agape

417

Happy Customers

98%

Success Rate

25+

Medical Employees

They Care About Your Health

Each team member contributes a unique set of skills and passion, united by a shared commitment to delivering exceptional healthcare experiences.

Co-Founder

Dr. S Sengupta, Ph.D

CEO & Co-founder

Venkat Nelabhotla

Chief Patent Counsel

Dr. Rena Patel, Ph.D., J.D.

Board Member

Krishna Gupta

Board Member

Mohanjit Jolly

Board Member

Rajeev Mantri

Need a Support?

Services

Appointment

Technology

Virtual Health

Frequently Asked Questions

Got a question? We're ready to answer! If you don't see your question listed here, please book an appointment.

How can I schedule an appointment at Agape?

Booking an appointment is easy! You can schedule it online through our website, call our dedicated appointment line, or use our user-friendly mobile app.

What services does Agape offer for families?

Is my health information secure?

How does Agape's Virtual Health Hub work?

What devices are compatible with virtual consultations?

Need a Support?

Services

Appointment

Technology

Virtual Health

Frequently Asked Questions

Got a question? We're ready to answer! If you don't see your question listed here, please book an appointment.

How can I schedule an appointment at Agape?

What services does Agape offer for families?

Is my health information secure?

How does Agape's Virtual Health Hub work?

What devices are compatible with virtual consultations?

Need a Support?

Services

Appointment

Technology

Virtual Health

Frequently Asked Questions

Got a question? We're ready to answer! If you don't see your question listed here, please book an appointment.

How can I schedule an appointment at Agape?

Booking an appointment is easy! You can schedule it online through our website, call our dedicated appointment line, or use our user-friendly mobile app.

What services does Agape offer for families?

Is my health information secure?

How does Agape's Virtual Health Hub work?

What devices are compatible with virtual consultations?

A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.